Why 23andMe Stock Dropped 29% in November

Why 23andMe Stock Dropped 29% in November
·2 min read

The company reported disappointing earnings results and has fallen victim to the recent sell-off in high-growth stocks.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting